Aethlon Medical (AEMD) investor relations material

Executive summary

• Annual Meeting scheduled for October 1, 2026, will be held virtually to maximize shareholder participation and convenience.

• Proxy materials, including the Proxy Statement and Annual Report, are available online and by mail to all shareholders of record as of August 10, 2026.

• Shareholders are encouraged to vote by proxy or online, with multiple voting methods available.

Voting matters and shareholder proposals

• Ten proposals will be voted on, including director elections, auditor ratification, equity plan amendments, capital structure changes, and approvals for future financing and warrant transactions.

• Board recommends voting “FOR” all proposals except Proposal 5, which is not explicitly recommended.

• Proposals include increasing authorized common and preferred shares, amending the equity incentive plan, and authorizing future share issuances for financing and warrant inducements.

• Shareholder proposals for the next annual meeting must be submitted by April 13, 2027, for inclusion.

Board of directors and corporate governance

• Board consists of five members, four of whom are independent under Nasdaq rules.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined responsibilities and independent chairs.

• Board meetings and committee attendance exceeded 75% for all directors in FY 2026.

• Code of Business Conduct and Ethics applies to all directors, officers, and employees.

• No family relationships or arrangements exist among directors or executive officers.